OSCR

Gut Modulators Alter BDNF/Cortisol Axis in Severe Obesity: Additional Secondary Outcomes from a Triple-Blind Randomized Trial.

Overview

Authors: Dayanne da Silva Borges1,2,3, Ricardo Fernandes4, Barbara Beatriz Philippi Martins1,2, Scheila Iria Kraus1,2, Erasmo Benicio Santos de Moraes Trindade3, Adair Roberto Soares Santos1,2
  1. Post-Graduate Program in Neuroscience, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-535, SC, Brazil; (B.B.P.M.); (S.I.K.)
  2. Laboratory of Neurobiology of Pain and Inflammation, Department of Physiological Sciences, Center of Biological Sciences, Federal University of Santa Catarina, Florianopolis 88040-535, SC, Brazil
  3. Post-Graduate Program in Nutrition, Research Group on Immunonutrition and Metabolism, Center of Health Sciences, Federal University of Santa Catarina, Florianopolis 88040-535, SC, Brazil
  4. Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79804-970, MS, Brazil
Journal: Life (Basel, Switzerland), volume 16, issue 6, article 924
Dates: received 23 April 2026; accepted 29 May 2026; published online 31 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/life16060924 · PMID 42355451 · PMCID PMC13302701 · OpenAlex W7163563172
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), other condition (population), depression (population), clinical / translational (subfield)
Methods: Statistics, Connectivity, Physiology & signal measures
Keywords: obesity, depression, anxiety, prebiotic, synbiotic
Topic: Gut microbiota and health (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 57 references in the paper

Abstract

The role of the gut–brain axis is crucial in maintaining homeostasis and regulating neural, hormonal, and immunological activity. This study aimed to evaluate the effects of prebiotics or synbiotics on serum markers related to emotional disorders in individuals with morbid obesity in a triple-blind, randomized trial. The sample consisted of 22 subjects (16 women and 6 men) with a mean age of 41.8 ± 8.5 years and a mean BMI of 47.7 ± 6.8 kg/m2. Serum BDNF concentrations decreased significantly after 30 days of prebiotic supplementation (p = 0.017). Serum cortisol concentrations increased in all groups between the evaluated time points, with the increase being statistically significant in the synbiotic-supplemented group (p = 0.028). Serum TNF-α concentrations increased significantly after 30 days of prebiotic supplementation when compared to the group’s baseline (p = 0.035); however, this variation did not produce a significant difference between the groups evaluated after 30 days of supplementation. The results suggest that a chronic, low-grade inflammatory state may be related to the neuroendocrine changes present in emotional disorders, but the absence of significant results in the primary outcomes is possibly due to severe underpowering. Findings from additional secondary outcomes are hypothesis-generating only, requiring confirmation in adequately powered trials.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The original data presented in the study are openly available in OSF as a public project ID: Bh6ud, available at: https://osf.io/bh6ud/overview, accessed on 22 April 2026.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Universidade Federal de Santa Catarina

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 53 references.

Cite

This paper

Borges, D. d. S., Fernandes, R., Martins, B. B. P., Kraus, S. I., Trindade, E. B. S. d. M., & Santos, A. R. S. (2026). Gut Modulators Alter BDNF/Cortisol Axis in Severe Obesity: Additional Secondary Outcomes from a Triple-Blind Randomized Trial. Life (Basel, Switzerland), 16(6), 924. https://doi.org/10.3390/life16060924

BibTeX

@article{borges2026gut,
author = {Borges, Dayanne da Silva and Fernandes, Ricardo and Martins, Barbara Beatriz Philippi and Kraus, Scheila Iria and Trindade, Erasmo Benicio Santos de Moraes and Santos, Adair Roberto Soares},
title = {{Gut Modulators Alter BDNF/Cortisol Axis in Severe Obesity: Additional Secondary Outcomes from a Triple-Blind Randomized Trial}},
journal = {Life (Basel, Switzerland)},
year = {2026},
month = may,
volume = {16},
number = {6},
pages = {924},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2075-1729},
doi = {10.3390/life16060924},
url = {https://doi.org/10.3390/life16060924},
pmid = {42355451},
pmcid = {PMC13302701}
}

RIS

TY - JOUR
AU - Borges, Dayanne da Silva
AU - Fernandes, Ricardo
AU - Martins, Barbara Beatriz Philippi
AU - Kraus, Scheila Iria
AU - Trindade, Erasmo Benicio Santos de Moraes
AU - Santos, Adair Roberto Soares
TI - Gut Modulators Alter BDNF/Cortisol Axis in Severe Obesity: Additional Secondary Outcomes from a Triple-Blind Randomized Trial
T2 - Life (Basel, Switzerland)
J2 - Life (Basel)
PY - 2026
DA - 2026/05/31
VL - 16
IS - 6
SP - 924
SN - 2075-1729
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/life16060924
UR - https://doi.org/10.3390/life16060924
LA - en
ER -

CSL-JSON

{
"id": "10.3390/life16060924",
"type": "article-journal",
"title": "Gut Modulators Alter BDNF/Cortisol Axis in Severe Obesity: Additional Secondary Outcomes from a Triple-Blind Randomized Trial",
"container-title": "Life (Basel, Switzerland)",
"author": [
{
"family": "Borges",
"given": "Dayanne da Silva"
},
{
"family": "Fernandes",
"given": "Ricardo"
},
{
"family": "Martins",
"given": "Barbara Beatriz Philippi"
},
{
"family": "Kraus",
"given": "Scheila Iria"
},
{
"family": "Trindade",
"given": "Erasmo Benicio Santos de Moraes"
},
{
"family": "Santos",
"given": "Adair Roberto Soares"
}
],
"container-title-short": "Life (Basel)",
"volume": "16",
"issue": "6",
"page": "924",
"DOI": "10.3390/life16060924",
"PMID": "42355451",
"PMCID": "PMC13302701",
"ISSN": "2075-1729",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/life16060924",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
31
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1021/acschemneuro.3c00127
Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders.
Journal: ACS chemical neuroscience
In common: 4 references
[2] doi:10.3390/nu14193967
Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders.
Journal: Nutrients
In common: clinical / translational, other condition, 3 references
[3] doi:10.1016/j.ebiom.2022.103908
Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNS.
Journal: EBioMedicine
In common: clinical / translational, other condition, 3 references
[4] doi:10.3389/fnins.2022.1048565
Mapping trends and hotspot regarding gastrointestinal microbiome and neuroscience: A bibliometric analysis of global research (2002-2022).
Journal: Frontiers in neuroscience
In common: 3 references
[5] doi:10.1038/s41380-024-02830-z [code]
Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.
Journal: Molecular psychiatry
In common: depression, clinical / translational, 2 references
[6] doi:10.1186/s13024-022-00548-6
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia.
Journal: Molecular neurodegeneration
In common: clinical / translational, 3 references
[7] doi:10.1111/cns.14081
Gut microbiota in brain tumors: An emerging crucial player.
Journal: CNS neuroscience & therapeutics
In common: other condition, 3 references
[8] doi:10.1186/s12866-022-02483-4
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides.
Journal: BMC microbiology
In common: depression, other condition, 2 references
[9] doi:10.1080/19490976.2022.2162306 [code]
The gut-microbiota-brain axis in a Spanish population in the aftermath of the COVID-19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles.
Journal: Gut microbes
In common: depression, clinical / translational, other condition, 2 references
[10] doi:10.1136/gpsych-2023-101374
Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications.
Journal: General psychiatry
In common: depression, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.